BD Achieves FDA Clearance for Rapid COVID-19 Test
The New Test Delivers Digital Results for Quick Clinical Decisions
BD (Becton, Dickinson and Company) (NYSE: BDX), renowned for its leadership in medical technologies, proudly announces the receipt of FDA 510(k) clearance for its BD Veritor™ System for SARS-CoV-2. This advanced testing solution is designed to detect COVID-19 antigens with remarkable speed, delivering results in approximately 15 minutes. The testing can be conducted in various settings, including doctors' offices, urgent care centers, and retail clinics.
What the 510(k) Clearance Means
This clearance is a significant milestone that will replace the current Emergency Use Authorization (EUA) version of the BD Veritor™ System, which has been operational since September 2020. The transition to 510(k) clearance reflects BD's ongoing commitment to providing reliable and efficient diagnostic tools for healthcare professionals. Beginning in early Fall 2025, this new clearance will enhance the capabilities and functionalities of the existing test.
Enhancing Clinical Decision-Making
"We are excited about this FDA clearance and its implications for healthcare providers," remarked Nikos Pavlidis, worldwide president of BD Diagnostic Solutions. "The BD Veritor™ System for SARS-CoV-2 has consistently shown to be a dependable test that simplifies the workflow and offers clear digital results, empowering clinicians to make timely decisions that ultimately improve patient care outcomes."
Technological Insights of the Test
The BD Veritor™ System utilizes a chromatographic digital lateral flow immunoassay technique which not only simplifies result interpretation but also enhances test reliability. It operates seamlessly with the BD Veritor™ Plus Analyzer, providing immediate results from nasal swab samples taken from patients who may show symptoms of COVID-19 within six days of the onset.
Contacting BD for More Information
Healthcare providers seeking more information about the testing solution can reach out to BD Customer Service at 800-638-8663. The BD team is dedicated to supporting healthcare professionals with high-quality patient care solutions.
About BD
BD is among the largest global medical technology companies, continually advancing healthcare through innovation. The organization is committed to enhancing medical discovery, diagnostics, and care delivery, striving to empower those on the frontlines of healthcare. With a workforce of more than 70,000 skilled employees, BD focuses on improving the safety and efficacy of clinical practices, enabling precise disease detection, and supporting researchers in the development of next-generation therapies and diagnostics. BD's international presence ensures that the company can actively address significant global health challenges through collaboration with various organizations to refine healthcare access and outcomes.
Frequently Asked Questions
What is the BD Veritor™ System for SARS-CoV-2?
The BD Veritor™ System is a rapid digital test that detects COVID-19 antigens in patients, providing results in around 15 minutes.
What does 510(k) clearance imply for the BD Veritor™ System?
The 510(k) clearance allows BD to continue using the product in clinical settings while replacing the previous Emergency Use Authorization.
What settings can utilize the BD Veritor™ System?
The test can be used in doctors' offices, urgent care facilities, and retail clinics, ensuring accessibility for timely diagnoses.
Who can contact BD for further queries?
Healthcare professionals can contact BD Customer Service at 800-638-8663 for inquiries or support related to the test.
How does the BD Veritor™ System enhance patient outcomes?
The test helps clinicians make informed decisions quickly, leading to more effective patient management and treatment.
